Immix Biopharma (IMMX) Shares Issued (2022 - 2026)

Immix Biopharma has disclosed Shares Issued across 5 years of filings, most recently posting $33532.0 for Q1 2026.

• Shares Issued for Q1 2026 came in at $33532.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $123.4 million (changed N/A YoY), and the FY2025 annual result was $107.4 million, up 573.47% from the prior year.
• Shares Issued came in at $33532.0 for Q1 2026 at Immix Biopharma, down from $107.4 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $107.4 million in Q4 2025 to a low of -$15.9 million in Q3 2024.
• The 5-year median for Shares Issued is $33532.0 (2026), against an average of $11.3 million.
• Peak annual rise in Shares Issued reached 9348.99% in 2024, while the deepest fall reached 97.6% in 2024.
• Immix Biopharma's Shares Issued stood at -$2.4 million in 2022, then surged by 92.93% to -$172382.0 in 2023, then jumped by 9348.99% to $15.9 million in 2024, then jumped by 573.54% to $107.4 million in 2025, then tumbled by 99.97% to $33532.0 in 2026.
• The last three Shares Issued figures came in at $33532.0 (Q1 2026), $107.4 million (Q4 2025), and $516.0 (Q3 2025), per Business Quant data.